品牌:TLC PharmaChem 标准品 对照品 杂质
发货:3天内
信息标签:TLC PharmaChem 标准品 对照品 杂质（8）,供应,化工,化学试剂
点击这里进行电话呼叫
点击这里QQ咨询
联系时一定要说在【贸易商务资源网】看到的将给您优惠！如果您也想和该公司一样在网站发信息有好排名，点击立即免费注册，发布产品推广。
TLC PharmaChem 标准品 对照品 杂质（8）
发布时间:2014-10-28 17:59:07 产品编号:GY-5-34869768 分享
价格:未填
品牌:TLC PharmaChem 标准品 对照品 杂质
发货:3天内
信息标签:TLC PharmaChem 标准品 对照品 杂质（8）,供应,化工,化学试剂
品牌:TLC PharmaChem 标准品 对照品 杂质
发货:3天内
信息标签:TLC PharmaChem 标准品 对照品 杂质（8）,供应,化工,化学试剂
| Lamotrigine-13C3 CAS No. 84057-84-1(non-d) C613C3H7Cl2N5 M.W. 259.07 L-011  |
Lamotrigine Dimer Impurity 2 C19H14Cl4N10 M.W. 524.20 L-0110  |
| Lamotrigine-13C-d3 C9H4Cl2N5D3 M.W. 260.10 L-012  |
Lamotrigine Impurity D CAS No. 661463-79-2 C9H5Cl2N3O2 M.W. 258.07 L-013  |
| Lamotrigine Related Compound C C9H6Cl2N4O M.W. 257.08 L-014  |
Lamotrigine Related Compound D C16H9Cl4N5O M.W. 429.10 L-015  |
| Lamotrigine Impurity C CAS No. 94213-23-7 C9H7Cl2N5 M.W. 256.10 L-016  |
Lamotrigine Impurity CAS No. N/A C8H3Cl2NO M.W. 200.03 L-017  |
| Lamotrigine Impurity E (2,3-Dichlorobenzoic Acid) CAS No. 50-45-3 C7H4Cl2O2 M.W. 191.01 L-018  |
Lamotrigine Dimer Impurity 1 C19H14Cl4N10 M.W. 524.20 L-019  |
| Lacidipine-d9 CAS No. 103890-78-4 C26H24NO6D9 M.W. 464.61 L-021  |
Lacidipine CAS No. 103890-78-4 C26H33NO6 M.W. 455.56 L-022  |
| Lacidipine-d10 CAS No. 103890-78-4(non-d) C26H23NO6D10 M.W. 465.62 L-023  |
Dehydro lacidipine C26H31NO6 M.W. 453.54 L-024  |
| cis-Lacidipine CAS No. 103890-79-5 C26H33NO6 M.W. 455.55 L-025  |
Lansoprazole CAS No. 103577-45-3 C16H14F3N3O2S M.W. 369.37 L-031  |
| Lansoprazole EP Impurity C CAS No. 103577-40-8 C16H14F3N3OS M.W. 353.37 L-0311  |
Lansoprazole EP Impurity D CAS No. 615-16-7 C7H6N2O M.W. 134.14 L-0312  |
| Lansoprazole EP Impurity E CAS No. 583-39-1 C7H6N2S M.W. 150.20 L-0313  |
Lansoprazole EP Impurity F CAS No. 168167-42-8 C14H12ClN3OS M.W. 305.79 L-0314  |
| Lansoprazole Sulfone N-Oxide C16H14F3N3O4S M.W. 401.37 L-0315  |
2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine C9H9ClF3NO M.W. 239.63 L-0316  |
| Lansoprazole Impurity H CAS No. 1346598-28-4 C23H16F3N5OS M.W. 467.48 L-0317  |
Lansoprazole Impurity I CAS No. N/A C23H16F3N5OS M.W. 467.48 L-0318  |
| Lansoprazole N-Trifuoroethyl Impurity CAS No. 1187926-84-6 C18H15F6N3O2S M.W. 451.39 L-0319  |
Lansoprazole EP Impurity B (Lansoprazole Sulfone) CAS No. 131926-99-3 C16H14F3N3O3S M.W. 385.37 L-032  |
| Lansoprazole N-(3-Methyl-4-Trifuoroethoxyl-Pyridin-2-yl) Impurity CAS No. N/A C25H22F6N4O3S M.W. 572.53 L-0320  |
(R)-Lansoprazole-d4 CAS No. 1246819-33-9 C16H12F3N3O2SD4 M.W. 375.41 L-0321  |
| Lansoprazole Thioxo Impurity CAS No. 1246819-06-6 C14H9N3OS M.W. 267.31 L-0322  |
Lansoprazole Related Compound 1 C14H13N3OS M.W. 271.34 L-0323  |
| Lansoprazole Related Compound 2 (Des(trifluoroethyl) Lansoprazole Sulfide) CAS No. 131926-97-1 C14H13N3OS M.W. 271.34 L-0324  |
Lansoprazole Related Compound 3 CAS No. 1083100-27-9 C25H22F6N4O2S M.W. 556.53 L-0325  |
| 5-Hydroxy Lansoprazole CAS No. 131926-98-2 C16H14F3N3O3S M.W. 385.37 L-033  |
Lansoprazole-d4 CAS No. 103577-45-3(non-d) C16H10F3N3O2SD4 M.W. 373.39 L-034  |
| 5-Hydroxy Lansoprazole Sulfide C16H14F3N3O2S M.W. 369.37 L-035  |
6-Hydroxy Lansoprazole Sulfide C16H14F3N3O2S M.W. 369.37 L-036  |
| (R)-(+)-Lansoprazole C16H14F3N3O2S M.W. 369.37 L-037  |
Lansoprazole Glucuronide CAS No. N/A C22H22F3N3O8S M.W. 545.50 L-038  |
| Lansoprazole EP Impurity A CAS No. 213476-12-1 C16H14F3N3O3S M.W. 385.37 L-039  |
Leflunomide CAS No. 75706-12-6 C12H9F3N2O2 M.W. 270.21 L-041  |
| Leflunomide Impurity F C12H9F3N2O2 M.W. 270.21 L-0410  |
Leflunomide Impurity G C12H12N2O2 M.W. 216.24 L-0411  |
| Leflunomide Impurity H CAS No. 24522-30-3 C10H7F3N2O M.W. 228.18 L-0412  |
Leflunomide-d4 CAS No. 75706-12-6 (non-d) C12H5F3N2O2D4 M.W. 274.24 L-042  |
| 2-Cyano-3OH-N-(4-trifluoromethylphenyl) crotonamide CAS No. 163451-81-8 C12H9F3N2O2 M.W. 270.21 L-043  |
2-Cyano-3OH-N-(4-trifluoromethylphenyl) crotonamide-d4 CAS No. 108605-62-5 C12H5F3N2O2D4 M.W. 274.24 L-044  |
| Leflunomide Impurity E C12H9F3N2O2 M.W. 270.21 L-045  |
Leflunomide Impurity B CAS No. 163451-81-8 C12H9F3N2O2 M.W. 270.21 L-046  |
| Leflunomide Impurity C CAS No. 61643-23-0 C12H9F3N2O2 M.W. 270.21 L-047  |
Leflunomide Impurity A CAS No. 455-14-1 C7H6F3N M.W. 161.13 L-048  |
| Leflunomide Impurity D CAS No. 42831-50-5 C5H5NO3 M.W. 127.10 L-049  |
Levetiracetam CAS No. 102767-28-2 C8H14N2O2 M.W. 170.21 L-051  |
| Levetiracetam-d6 CAS No. 102767-28-2(non-d) C8H8D6N2O2 M.W. 176.25 L-052  |
Levetiracetam metabolite CAS No. 102849-49-0 C8H13NO3 M.W. 171.20 L-053  |
| Levetiracetam Impurity B CAS No. 358629-47-7 C8H12N2O2 M.W. 168.20 L-054  |
Levetiracetam Impurity C CAS No. 72762-00-6 C5H5NO M.W. 95.10 L-055  |
| Levetiracetam Impurity D CAS No. 103765-01-1 C8H14N2O2 M.W. 170.21 L-056  |
Levetiracetam Imurity (L-2-Aminobutanamide HCl,S-2-Aminobutanamide HCl) C4H10N2O.HCl M.W. 102.14 36.46 L-057  |
| Levetiracetam Impurity 3 CAS No. N/A C8H15ClN2O2 M.W. 206.67 L-058  |
Levetiracetam Impurity A CAS No. 67118-31-4 C8H13NO3 M.W. 171.20 L-059  |
| Lidocaine-d6 HCl CAS No. 1215823-29-2 (free base)) C14H16N2OD6. HCl M.W. 240.38 36.46 L-061  |
Lidocaine Impurity F C14H22N2O . HCl M.W. 234.34 36.46 L-0610  |
| Lidocaine Impurity G C13H20N2O . HCl M.W. 220.32 36.46 L-0611  |
Lidocaine Impurity K CAS No. 50295-20-0 C13H20N2O. HCl M.W. 220.32 36.46 L-0612  |
| 3'-Hydroxy Lidocaine CAS No. 34604-55-2 C14H22N2O2 M.W. 250.34 L-0614  |
Lidocaine Impurity A C8H11N M.W. 121.18 L-0615  |
| Lidocaine Impurity C CAS No. 2198-53-0 C10H13NO M.W. 163.22 L-0616  |
Lidocaine Impurity H C10H12ClNO M.W. 197.67 L-0618  |
| Lidocaine Impurity I C14H22N2O M.W. 234.34 L-0619  |
Monoethylglycinexylidine HCl (Impurity D) CAS No. 7729-94-4 C12H18N2O.HCl M.W. 206.29 36.46 L-062  |
| Lidocaine Impurity J CAS No. N/A C14H22N2O M.W. 234.34 L-0620  |
Lidocaine Impurity 1 (2-(Diethylamino)-N-(Diethylaminoyl)acetamide) CAS No. N/A C11H23N3O2 M.W. 229.32 L-0621  |
| Lidocaine Impurity 2 (2-[(Diethylcarbamoyl)amino]-N, N-Diethylacetamide) CAS No. N/A C11H23N3O2 M.W. 229.32 L-0622 ![Lidocaine Impurity 2 (2-[(Diethylcarbamoyl)amino]-N, N-Diethylacetamide)](http://www.tlcpharmachem.com/product_images/L-0622.jpg) |
Lidocaine Impurity 3 C14H19N3 M.W. 229.33 L-0623  |
| Lidocaine CAS No. 137-58-6 C14H22N2O M.W. 234.34 L-0624  |
Monoethyl Glycinexylidine-d6 HCl CAS No. 1216698-89-3 (free base) C12H12N2OD6. HCl M.W. 212.33 36.46 L-063  |
| Glycinexylidide HCl CAS No. 18865-38-8 C10H14N2O.HCl M.W. 178.24 36.46 L-064  |
Glycinexylidide-d6 CAS No. 18865-38-8(non-d) C10H8N2OD6 M.W. 184.27 L-065  |
| Lidocaine-d10 CAS No. 137-58-6 (non-d) C14H12N2OD10 M.W. 244.40 L-066  |
2,6-Xylidine-d6 HCl C8H5ND6. HCl M.W. 127.22 36.46 L-067  |
| Lidocaine Impurity B (Lidocaine N-Oxide) CAS No. 2903-45-9 C14H22N2O2 M.W. 250.34 L-068  |
Lidocaine Impurity E CAS No. 745798-07-6 C20H25N3O2 M.W. 339.44 L-069  |
| Linezolid-d3 CAS No. 1127120-38-0 C16H17FN3O4D3 M.W. 340.37 L-071  |
Thio Linezolid (Linezolid Related Compound B) CAS No. N/A C16H20FN3O3S M.W. 353.42 L-0710  |
| Linezolid Related Compound A CAS No. 168828-84-0 C14H16FN5O3 M.W. 321.31 L-0711  |
Linezolid Related Compound C CAS No. 168828-90-8 C14H18FN3O3 M.W. 295.32 L-0712  |
| Defluoro Linezolid CAS No. 556801-15-1 C16H21N3O4 M.W. 319.36 L-0713  |
Linezolid Impurity D HCl CAS No. 1391068-25-9 C15H22FN3O3. HCl M.W. 311.36 36.46 L-0714  |
| Linezolid Dimer CAS No. 908143-04-4 C30H35F2N5O7 M.W. 615.64 L-0715  |
R-Linezolid-d3 CAS No. 1127120-38-0 C16H17FN3O4D3 M.W. 340.37 L-0716  |
| Linezolid Impurity (N,O-Desethylene Linezolid) CAS No. 1219708-30-1 C14H18FN3O4 M.W. 311.32 L-0717  |
Linezolid impurity PNU177636 C20H26FN3O5 M.W. 407.45 L-0718  |
| Linezolid Related Compound (Linezolid N-Oxide) CAS No. 189038-36-6 C16H20FN3O5 M.W. 353.35 L-0719  |
Linezolid-13C-d3 CAS No. 165800-03-3 C1513CH17D3FN3O4 M.W. 341.36 L-072  |
| Linezolid related Compound CAS No. 174649-09-3 C15H19FN2O6S M.W. 374.39 L-0720  |
Linezolid Related Impurity 1 CAS No. 1532560-87-4 C13H20FN3O2 M.W. 269.32 L-0721  |
| Linezolid Related Impurity 2 CAS No. N/A C15H22FN3O3 M.W. 311.36 L-0722  |
Racemic-Linezolid Impurity PNU140155 C15H22FN3O3 M.W. 311.36 L-0723  |
| Linezolid CAS No. 165800-03-3 C16H20FN3O4 M.W. 337.35 L-073  |
Linezolid-13C2-d3 C16H17FN3O4D3 M.W. 342.35 L-074  |
| Benzyl 3-Fluoro-4-(4-morpholinyl)phenyl)carbamate CAS No. 168828-81-7 C18H19FN2O3 M.W. 330.36 L-076  |
Linezolid Impurity ((5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-hydroxymethyl-2-oxazolidinone) CAS No. 168828-82-8 C14H17FN2O4 M.W. 296.30 L-077 ![Linezolid Impurity ((5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-hydroxymethyl-2-oxazolidinone)](http://www.tlcpharmachem.com/product_images/L-077.jpg) |
| R-Linezolid CAS No. 872992-20-6 C16H20FN3O4 M.W. 337.35 L-078  |
Linezolid Impurity PNU140155 C15H22FN3O3 M.W. 311.36 L-079  |
| Lisinopril-d5 CAS No. 83915-83-7 C21H26N3O5D5 M.W. 410.53 L-081  |
Lisinopril Impurity C ((S, S, S)-Diketopiperazine) CAS No. 328385-86-0 C21H29N3O4 M.W. 387.48 L-0810  |
| Lisinopril C21H31N3O5 M.W. 405.50 L-082  |
Lisinopril Impurity A CAS No. NA C10H13NO2 M.W. 179.22 L-083  |
| Lisinopril Impurity D CAS No. NA C21H29N3O4 M.W. 387.48 L-085  |
Lisinopril Impurity E CAS No. 85955-59-5 C21H31N3O5 M.W. 405.50 L-086  |
| Lisinopril Impurity F CAS No. NA C21H37N3O5 M.W. 411.55 L-087  |
Lisinopril CPP Lysine Impurity CAS No. 138247-43-5 C16H24N2O4 M.W. 308.38 L-088  |
| Lisinopril Impurity H (Dimer Impurity) CAS No. N/A C37H53N5O8 M.W. 695.86 L-089  |
Loxapine CAS No. 54810-23-0 C18H18ClN3O M.W. 327.82 L-089001  |
| Loxapine-d8 CAS No. 54810-23-0(non-d) C18H10ClN3OD8 M.W. 335.86 L-089002  |
Loxapine N+-Glucuronide C24H27ClN3O7 M.W. 504.95 L-089003  |
| Loxapine N-Oxide C18H18ClN3O2 M.W. 343.82 L-089004  |
7-Hydroxy-Loxapine CAS No. N/A C18H18ClN3O2 M.W. 343.82 L-089005  |
| 7-Hydroxy-Loxapine-d8 CAS No. N/A C18H10ClN3O2D8 M.W. 351.86 L-089006  |
7-Hydroxy-Loxapine N-Oxide CAS No. N/A C18H18ClN3O3 M.W. 359.82 L-089007  |
| 7-Hydroxy-Loxapine Sulfate CAS No. N/A C18H18ClN3O5S M.W. 423.88 L-089008  |
7-Hydroxy-Loxapine-O-Glucuronide CAS No. N/A C24H26ClN3O8 M.W. 519.94 L-089009  |
| 8-Hydroxy-Loxapine CAS No. N/A C18H18ClN3O2 M.W. 343.82 L-089010  |
8-Hydroxy-Loxapine-d8 CAS No. N/A C18H10ClN3O2D8 M.W. 351.86 L-089011  |
| 8-Hydroxy-Loxapine N-Oxide CAS No. N/A C18H18ClN3O3 M.W. 359.82 L-089012  |
8-Hydroxy-Loxapine Sulfate CAS No. N/A C18H18ClN3O5S M.W. 423.88 L-089013  |
| 8-Hydroxy-Loxapine-O-Glucuronide CAS No. N/A C24H26ClN3O8 M.W. 519.94 L-089014  |
Lurasidone Hydrochloride CAS No. 367514-88-3 C28H36N4O2S M.W. 492.69 L-090001  |
| Lurasidone-d8 C28H28N4O2SD8 M.W. 500.74 L-090002  |
Lurasidone Inactive metabolite 14283 C28H36N4O3S M.W. 508.69 L-090003  |
| Lurasidone Inactive metabolite 14326 C28H36N4O3S M.W. 508.69 L-090004  |
Lurasidone Inactive metabolite 14283-d8 CAS No. N/A C28H28N4O3SD8 M.W. 516.74 L-090005  |
| Lurasidone Inactive metabolite 14326-d8 CAS No. N/A C28H28N4O3SD8 M.W. 516.74 L-090006  |
Lurasidone Sulfoxide C28H36N4O3S M.W. 508.69 L-090007  |
| Loperamide HCl CAS No. 34552-83-5 C29H33ClN2O2.HCl M.W. 513.51 L-091  |
Lapachol CAS No. 84-79-7 C15H14O3 M.W. 242.28 L-091001  |
| Desmethyl loperamide HCl CAS No. 66164-07-6 C28H31ClN2O2.HCl M.W. 499.48 L-092  |
2’-O-Methyl Lactose CAS No. 77667-98-2 C13H24O11 M.W. 356.33 L-092001  |
| Loperamide-d6 HCl CAS No. 34552-83-5 (non-d) C29H27ClN2O2D6 M.W. 483.09 L-093  |
Lincomycin B HCl CAS No. 11021-35-5 C17H32N2O6S HCl M.W. 392.52 36.46 L-093001  |
| epi-Lincomycin-2,7-dipalmitate C51H95NO8S M.W. 882.39 L-093002  |
Lincomycin-2,7-dipalmitate C51H95NO8S M.W. 882.39 L-093003  |
| Lincomycin impurity A C18H34N2O6S M.W. 406.55 L-093004  |
Lincomycin impurity C C17H32N2O6S M.W. 392.52 L-093005  |
| Lincomycin 2,4-Phosphate CAS No. N/A C18H33N2O8PS M.W. 468.51 L-093006  |
7-epi Lincomycin CAS No. 26389-84-4 C18H34N2O6S M.W. 406.55 L-093007  |
| Loperamide N-Oxide C29H33ClN2O3 M.W. 493.05 L-094  |
Lumiflavin CAS No. 1088-56-8 C13H12N4O2 M.W. 256.27 L-094001  |
| Loperamide Impurity A CAS No. N/A C35H37ClN2O2 M.W. 553.15 L-095  |
Lorcaserin HCl Hemihydrate CAS No. 856681-05-5 C11H14ClN. HCl. 0.5 H2O M.W. 195.69 36.46 0.5 18.02 L-095001  |
| Lorcaserin-D4 C11H10ClND4 M.W. 199.72 L-095002  |
Lorcaserin impurity A C11H14ClN M.W. 195.69 L-095003  |
| Lorcaserin impurity B CAS No. 953789-37-2 C11H15Cl2N . HCl M.W. 232.15 36.46 L-095004  |
Lorcaserin impurity C C13H16ClNO M.W. 237.73 L-095005  |
| Lorcaserin impurity D CAS No. 1030624-36-2 C11H14ClNO2 M.W. 227.69 L-095006  |
Lorcaserin impurity E C11H14ClN . C4H6O6 M.W. 195.69 150.09 L-095007  |
| Lorcaserin Dechloro Impurity CAS No. N/A C11H15N M.W. 161.25 L-095008  |
Lorcaserin N-Oxide Impurity CAS No. N/A C11H14ClNO M.W. 211.69 L-095009  |
| Lorcaserin Lactam Impurity CAS No. N/A C11H12ClNO M.W. 209.68 L-095010  |
Lorcaserin 5-Methyl Isomer CAS No. N/A C11H14ClN M.W. 195.69 L-095011  |
| Lactitol Impurity B CAS No. N/A C12H24O11 M.W. 344.32 L-097001  |
Loratadine (Desloratadine Impurity E) CAS No. 79794-75-5 C22H23ClN2O2 M.W. 382.89 L-101  |
| 3-Hydroxy Desloratadine Pyridine N-oxide C19H19ClN2O2 M.W. 342.83 L-1010  |
3-Hydroxy desloratadine-d4 C19H15ClN2OD4 M.W. 330.85 L-1011  |
| 5-Hydroxy desloratadine CAS No. 117811-12-8 C19H19ClN2O M.W. 326.83 L-1012  |
6-Hydroxy Desloratadine CAS No. 119410-05-8 C19H19ClN2O M.W. 326.83 L-1013  |
| 3-Hydroxy Desloratadine C19H19ClN2O M.W. 326.83 L-1014  |
Desloratadine Pyridine N-Oxide CAS No. 169253-26-3 C19H19ClN2O M.W. 326.83 L-1015  |
| Desloratadine Impurity 1 C19H19ClN2 M.W. 310.83 L-1016  |
Desloratadine Impurity 2 CAS No. 117811-13-9 C19H19ClN2 M.W. 310.83 L-1017  |
| Desloratadine Impurity 3 C19H19ClN2 M.W. 310.83 L-1018  |
Desloratadine Impurity 4 C20H21ClN2 M.W. 324.86 L-1019  |
| Loratadine EP Impurity D (Desloratadine) CAS No. 100643-71-8 C19H19ClN2 M.W. 310.83 L-102  |
Desloratadine Impurity 5 CAS No. 38092-88-5 C20H21ClN2 M.W. 324.86 L-1020  |
| Desloratadine Impurity 6 CAS No. 38092-90-9 C20H21ClN2 M.W. 324.86 L-1021  |
Loratadine EP Impurity B CAS No. 31251-41-9 C14H10ClNO M.W. 243.69 L-1022  |
| Loratadine Impurity D CAS No. 38089-93-9 C20H23ClN2O M.W. 342.87 L-1023  |
Loratadine Impurity E CAS No. 133330-60-6 C14H9Cl2NO M.W. 278.14 L-1024  |
| Loratadine EP Impurity A CAS No. 133284-74-9 C22H25ClN2O3 M.W. 400.91 L-1025  |
Loratadine EP Impurity C CAS No. 165739-83-3 C22H22Cl2N2O2 M.W. 417.34 L-1026  |
| N-Formyl Desloratadine (Desloratadine Impurity D) C20H19ClN2O M.W. 338.84 L-1027  |
Loratadine EP Impurity G (Methyl Loratadine) CAS No. 38092-89-6 C20H21ClN2 M.W. 324.86 L-1028  |
| Iso Desloratadine HCl CAS No. 183198-49-4 (free base) C19H19ClN2. HCl M.W. 310.83 36.46 L-1029  |
Loratadine-d5 CAS No. 1020719-57-6 C22H18D5ClN2O2 M.W. 387.92 L-103  |
| Desloratadine N-Hydroxypiperidine CAS No. 1193725-73-3 C19H19ClN2O M.W. 326.83 L-1032  |
Desloratadine Impurity Disodium Salt CAS No. N/A C25H23ClN2O6. 2 Na M.W. 482.92 2 22.99 L-1033  |
| Desloratadine Impurity A CAS No. 38092-95-4 C19H20N2 M.W. 276.38 L-1034  |
Desloratadine Impurity B CAS No. 117796-50-6 C19H19BrN2 M.W. 355.28 L-1035  |
| Desloratadine Impurity C CAS No. 117811-20-8 C19H17ClN2 M.W. 308.81 L-1036  |
4-[[3-[2-(3-Chlorophenyl)ethyl]-2-pyridinyl]carbonyl]-1-piperidinecarboxylic Acid CAS No. 107256-32-6 C20H21ClN2O3 M.W. 372.85 L-1038 ![4-[[3-[2-(3-Chlorophenyl)ethyl]-2-pyridinyl]carbonyl]-1-piperidinecarboxylic Acid](http://www.tlcpharmachem.com/product_images/L-1038.jpg) |
| 11-Fluoro Desloratadine CAS No. 298220-99-2 C19H20ClFN2 M.W. 330.84 L-1039  |
Descarboethoxy loratadine-d5 CAS No. 79794-75-5(non-d) C19H14D5ClN2.HCl M.W. 315.86 L-104  |
| N-Acetyldesloratadine CAS No. 117796-52-8 C21H21ClN2O M.W. 352.87 L-1041  |
Loratadine EP Impurity F CAS No. 125743-80-8 C22H24ClFN2O2 M.W. 402.90 L-1042  |
| 3-Hydroxy desloratadine HCl CAS No. 19410-08-1 C19H19ClN2O.HCl M.W. 326.83 36.46 L-105  |
4-Hydroxymethyl loratadine CAS No. 609806-40-8 C23H2ClN2O3 M.W. 412.91 L-106  |
| 3-Hydroxy desloratadine glucuronide CAS No. 774538-89-5 C25H27ClN2O7 M.W. 502.96 L-107  |
2-Hydroxymethyl loratadine CAS No. 609806-39-5 C23H2ClN2O3 M.W. 412.91 L-108  |
| Losartan potassium salt CAS No. 124750-99-8 C22H22ClKN6O M.W. 461.01 L-111  |
Losartan Impurity J CAS No. 1006062-27-6 C24H25ClN6O2 M.W. 464.96 L-1110  |
| Losartan Impurity K CAS No. 1159977-26-0 C21H20Cl2N6 M.W. 427.34 L-1111  |
Losartan N1-Glucuronide C28H31ClN6O7 M.W. 599.05 L-1113  |
| Losartan Carboxylic Acid Acyl-Beta-D-Glucuronide CAS No. N/A C29H31ClN6O7 M.W. 611.06 L-1114  |
Losartan Related Compound A CAS No. 1247750-67-0 C22H20ClN3O M.W. 377.88 L-1115  |
| Losartan Related Compound B CAS No. N/A C22H22ClN3O M.W. 379.89 L-1116  |
Losartan Impurity C (Isolosartan) CAS No. 114799-13-2 C22H23ClN6O M.W. 422.92 L-1117  |
| Losartan Impurity (5-(4'-Methylbiphenyl-2-yl)-1-Trityl-1H-Tetrazole) CAS No. 124750-53-4 C33H26N4 M.W. 478.60 L-1118  |
N-Trithyl Losartan CAS No. 124751-00-4 C41H37ClN6O M.W. 665.24 L-1119  |
| Losartan Carboxylic Acid CAS No. 124750-92-1 C22H21ClN6O2 M.W. 436.90 L-112  |
Losartan Impurity B CAS No. 1159977-48-6 C44H44Cl2N12O2 M.W. 843.83 L-1120  |
| Losartan Carboxaldehyde CAS No. 114798-36-6 C22H21ClN6O M.W. 420.91 L-1121  |
Losartan Trityl Ether (Impurity I) CAS No. 1006062-28-7 C41H37ClN6O M.W. 665.24 L-1122  |
| Losartan Impurity D C8H11ClN2O M.W. 186.64 L-1123  |
Losartan Impurity E C14H12N4 M.W. 236.28 L-1124  |
| Losartan-d4 CAS No. 124750-99-8(non-d) C22H19D4ClN6O M.W. 425.94 L-113  |
Losartan Carboxylic Acid-d4 CAS No. 1246820-62-1 C22H17ClN6O2D4 M.W. 440.93 L-114  |
| Losartan N2-glucuronide C28H31ClN6O7 M.W. 599.05 L-115  |
Losartan Potassium Impurity L CAS No. 230971-71-8 C44H44Cl2N12O M.W. 827.83 L-116  |
| Losartan Potassium Impurity M CAS No. 230971-72-9 C44H44Cl2N12O M.W. 827.83 L-117  |
Losartan Impurity G CAS No. 165276-38-0 C22H21ClN6 M.W. 404.91 L-119  |
| Lovastatin hydroxy acid sodium salt CAS No. 75225-51-3 C24H37O6.Na M.W. 444.55 L-121  |
Lovastatin Impurity F C24H34O5 M.W. 402.54 L-1210  |
| Des(2-methylbutyrate) lovastatin hydroxy acid sodium salt CAS No. 75225-51-3 C19H29O5.Na M.W. 360.43 L-122  |
Lovastatin-d3 Hydroxy Acid Sodium Salt CAS No. 1279029-75-2 C24H34O6D3.Na M.W. 424.58 22.99 L-123  |
| Lovastatin-d9 C24H27O5D9 M.W. 413.61 L-124  |
Lovastatin-d9 hydroxy acid sodium salt C24H28O6D9.Na M.W. 430.61 22.99 L-125  |
| Lovastatin-d3 CAS No. 1002345-93-8 C24H33O5D3 M.W. 407.5 L-126  |
Lovastatin C24H36O5 M.W. 404.55 L-127  |
| Hydroxy Lovastatin CAS No. N/A C24H36O7 M.W. 436.55 L-128  |
Lovastatin Dimer C48H72O10 M.W. 809.10 L-129  |
| Levocetirizine-d4 CAS No. 130018-77-8 C21H21ClN2O3D4 M.W. 392.92 L-131  |
N-Benzyl-2-[2-[(2-hydroxyethyl)amino]ethoxy]acetamide CAS No. 1391053-09-0 C13H20N2O3 M.W. 252.32 L-1310 ![N-Benzyl-2-[2-[(2-hydroxyethyl)amino]ethoxy]acetamide](http://www.tlcpharmachem.com/product_images/L-1310.jpg) |
| Levocetirizine Impurity 1 C28H32ClN3O2 M.W. 478.04 L-1311  |
4-Chlorobenzhydrylimine CAS No. NA C13H10ClN M.W. 215.68 L-132  |
| 2-Chlorobenzhydryl amine CAS No. 5267-39-0 C13H12ClN M.W. 217.70 L-133  |
N-Benzyl-2-chloro-N(chloroacetyl)acetamide CAS No. NA C11H11Cl2NO2 M.W. 260.12 L-134  |
| [2-[4-[4-chlorophenylmethyl]-1-piperazinyl]-ethoxy]acetamide CAS No. NA C15H22ClN3O2 M.W. 311.81 L-135 ![[2-[4-[4-chlorophenylmethyl]-1-piperazinyl]-ethoxy]acetamide](http://www.tlcpharmachem.com/product_images/L-135.jpg) |
1-Benzylaziridin-2-one CAS No. NA C9H9NO M.W. 147.18 L-136  |
| 2-(p-Chlorobenzhydryl piperazine)-[(N,N'-bis(2-ethoxy acetic acid)] CAS No. NA C25H32ClN2O6 M.W. 492.00 L-137 ![2-(p-Chlorobenzhydryl piperazine)-[(N,N'-bis(2-ethoxy acetic acid)]](http://www.tlcpharmachem.com/product_images/L-137.jpg) |
Levocetetrizine N-Oxide CAS No. NA C21H25ClN2O4 M.W. 404.90 L-138  |
| levocetirizine Impurity C17H19ClN2 M.W. 286.81 L-139  |
Linuron-d6 CAS No. 330-55-2 (non-d) C9H4Cl2N2O2D6 M.W. 255.13 L-151  |
| Letrozole-d4 CAS No. 1133712-96-5 C17H7N5D4 M.W. 289.33 L-161  |
Carbinol metabolite of Letrozole C15H10N2O M.W. 234.26 L-162  |
| Letrozole C17H11N5 M.W. 285.31 L-163  |
Letrozole Related Compound A CAS No. NA C17H11N5 M.W. 285.31 L-164  |
| Letrozole Impurity B CAS No. N/A C22H13N3 M.W. 319.39 L-165  |
Letrozole Impurity C CAS No. 112809-25-3 C10H8N4 M.W. 184.20 L-166  |
| R-Lercanidipine C36H41N3O6 M.W. 611.74 L-171  |
Lercanidipine Impurity A C19H22N2O6 M.W. 374.40 L-1710  |
| Lercanidipine Impurity C21H26N2O6 M.W. 402.45 L-1712  |
Lercanidipine Dimethyl Ester Impurity CAS No. N/A C17H18N2O6 M.W. 346.34 L-1713  |
| Lercanidipine Ethyl Methyl Ester Impurity (Impurity 5) CAS No. 39562-70-4 C18H20N2O6 M.W. 360.37 L-1714  |
Lercanidipine Ethyl Impurity (Impurity 4) CAS No. N/A C37H43N3O6 M.W. 625.77 L-1715  |
| Lercanidipine Impurity 6 C36H41N3O6 M.W. 611.74 L-1716  |
R-Lercanidipine-d3 C36H38D3N3O6 M.W. 614.74 L-172  |
| S-Lercanidipine C36H41N3O6 M.W. 611.74 L-173  |
S-Lercanidipine-d3 C36H38N3O6 M.W. 614.74 L-174  |
| Lercanidipine Impurity D HCl (Dehydro Lercanidipine HCl) CAS No. 887769-34-8 (free base) C36H39N3O6.HCl M.W. 609.73 36.46 L-175  |
Lercanidipine HCl CAS No. 132866-11-6 C36H41N3O6.HCl M.W. 611.74 36.46 L-176  |
| Lercanidipine Impurity B CAS No. 1119226-97-9 C35H37N3O6 M.W. 595.70 L-177  |
Lercanidipine-13C-d3 HCl C35H38N3O613CD3. HCl M.W. 615.75 36.46 L-178  |
| Lercanidipine Impurity C C38H45N3O6 M.W. 639.80 L-179  |
Lithocholic-2,2,3,4,4-d5 Acid CAS No. 434-13-9 (non-d) C24H35O3D5 M.W. 381.61 L-181  |
| Lithocholic-2,2,4,4-d4 Acid CAS No. 434-13-9 (non-d) C24H36O3D4 M.W. 380.61 L-182  |
Taurolithocholic-2,2,3,4,4-D5 Acid C26H40NO5SD5 M.W. 488.75 L-183  |
| Taurolithocholic-2,2,4,4-D4 Acid C26H41NO5SD4 M.W. 487.75 L-184  |
Lasofoxifene CAS No. 180916-16-9 C28H31NO2 M.W. 413.56 L-191  |
| Lasofoxifene-d4 CAS No. 180916-16-9 (non-d) C28H27NO2D4 M.W. 417.59 L-192  |
Lasofoxifene glucuronide C34H39NO8 M.W. 589.69 L-193  |
| rac-Lasofoxifene-d5 C28H26NO2D5 M.W. 418.59 L-194  |
Lamivudine-13C-d2 CAS No. 134678-17-4 C8H9N3O3SD2 M.W. 232.26 L-201  |
| Lamivudine-13C-15N2 C8H11N3O3S M.W. 232.23 L-202  |
Lamivudine CAS No. 134678-17-4 C8H11N3O3S M.W. 229.26 L-203  |
| Lamivudine Impurity B C8H11N3O3S M.W. 229.26 L-204  |
Lamivudine acid C8H9N3O4S M.W. 243.24 L-205  |
| 5'-Epi Lamivudine CAS No. 139757-68-9 C8H11N3O3S M.W. 229.26 L-206  |
Lamivudine S-oxide C8H11N3O4S M.W. 245.26 L-207  |
| Lubiprostone CAS No. 333963-40-9 C20H32F2O5 M.W. 390.47 L-211  |
Lubiprostone-d4 CAS No. 333963-40-9 (non-d) C20H28F2O5D4 M.W. 394.50 L-212  |
| 15-Hydroxy lubiprostone-mixture of isomers C20H34F2O5 M.W. 392.49 L-213  |
15-Hydroxy lubiprostone-d4 C20H30F2O5D4 M.W. 396.51 L-214  |
| Lubiprostone CAS No. 136790-76-6 C20H32F2O5 M.W. 390.47 L-215  |
Lubiprostone-d7 CAS No. 333963-40-9 (non-d) C20H25F2O5D7 M.W. 397.51 L-216  |
| Lubiprostone related compound 1 C20H32F2O5 M.W. 390.47 L-217  |
Lubiprostone related compound 2 C20H32F2O5 M.W. 390.47 L-218  |
| Levonorgestrel Sulfate Sodium Salt C21H27O5S.Na M.W. 391.51 22.99 L-221  |
Levonorgestrel Impurity P CAS No. 100021-05-4 C21H28O2 M.W. 312.46 L-2210  |
| Levonorgestrel Impurity C C23H28O M.W. 320.48 L-2211  |
Levonorgestrel Impurity M CAS No. 51087-61-7 C21H26O2 M.W. 310.44 L-2212  |
| Aromatic levonorgestrel C22H28O2 M.W. 324.47 L-2213  |
Delta1 (10)-4, 5-dihydro-levonorgestrel C21H28O2 M.W. 312.46 L-2214  |
| Levonorgestrel Impurity A CAS No. 110785-09-6 C21H26O2 M.W. 310.44 L-2215  |
Levonorgestrel Impurity S CAS No. N/A C22H30O2 M.W. 326.48 L-2216  |
| Levonorgestrel Impurity O C22H32O3 M.W. 344.50 L-2217  |
Levonorgestrel Impurity L (18-Methylester-4-ene-3,17-dione) CAS No. 21800-83-9 C19H26O2 M.W. 286.42 L-2218  |
| Levonorgestrel Impurity B C21H28O2 M.W. 312.46 L-2219  |
Levonorgestrel-d6 ((-)-Norgestrel-d6) ((-)-Norgestrel-2,2,4,6,6,10-d6) CAS No. 793-67-7 (non-d) C21H22O2D6 M.W. 318.49 L-222  |
| 10-alpha-Hydroxy Levonorgestrel C21H28O3 M.W. 328.46 L-2220  |
Levonorgestrel Impurity V C22H28O2 M.W. 324.47 L-2221  |
| Levonorgestrel Impurity W C21H24O2 M.W. 308.42 L-2222  |
Levonorgestrel Impurity R CAS No. 2322-77-2 C20H28O2 M.W. 300.44 L-2223  |
| Levonorgestrel Impurity Q CAS No. 1038-28-4 C20H30O2 M.W. 302.46 L-2224  |
Levonorgestrel Impurity T CAS No. 799-43-9 C22H30O2 M.W. 326.48 L-2225  |
| Delta-5(10)-8-alfa-Levonorgestrel CAS No. N/A C21H28O2 M.W. 312.46 L-2226  |
Levonorgestrel Impurity J (6-Keto Levonorgestrel) CAS No. 1175109-63-3 C21H26O3 M.W. 326.44 L-2227  |
| Levonorgestrel Impurity D CAS No. 32419-58-2 C21H30O M.W. 298.47 L-2228  |
D-(-)-Norgestrel (Levonorgestrel) CAS No. 797-63-7 C21H28O2 M.W. 312.46 L-223  |
| 10-beta-Hydroxy Levonorgestrel CAS No. 21508-50-9 C21H28O3 M.W. 328.46 L-224  |
6-alfa-Hydroxy Levonorgestrel C21H28O3 M.W. 328.46 L-225  |
| Levonorgestrel Impurity H (6-beta-Hydroxy Levonorgestrel) C21H28O3 M.W. 328.46 L-226  |
Levonorgestrel Impurity N CAS No. 4222-96-2 C19H26O2 M.W. 286.42 L-229  |
| Levofloxacin C18H20FN3O4 M.W. 361.38 L-231  |
Levofloxacin Related Compound C C20H24FN3O4 M.W. 389.43 L-2310  |
| Levofloxacin-d8 CAS No. 1217716-71-6 C18H12FN3O4D8 M.W. 369.42 L-2311  |
Levofloxacin Diformyl Impurity CAS No. 151377-74-1 C18H18FN3O6 M.W. 391.36 L-2312  |
| Levofloxacin N-oxide CAS No. 117678-38-3 C18H20FN3O5 M.W. 377.38 L-2313  |
Levofloxacin-Acyl-D-Glucuronide CAS No. 160962-46-9 C24H28FN3O10 M.W. 537.50 L-2314  |
| 9-Piperazine Levofloxacin Impurity CAS No. 178912-62-4 C18H20FN3O4 M.W. 361.38 L-2315  |
Descarboxyl Levofloxacin CAS No. 178964-53-9 C17H20FN3O2 M.W. 317.37 L-2316  |
| Levofloxacin Tetrafluoro Impurity 1 CAS No. 110548-02-2 C15H15F4NO4 M.W. 349.28 L-2317  |
Levofloxacin Tetrafluoro Impurity 2 CAS No. 103995-33-1 C14H12F4O4 M.W. 320.24 L-2318  |
| Levofloxacin Related Compound B C13H9F2NO4 M.W. 281.22 L-232  |
N-Desmethyl Levofloxacin (Levofloxacin Related Compound A) C18H20FN3O4 M.W. 347.35 L-233  |
| N-Desmethyl Levofloxacin-d8 C17H10FN3O4D8 M.W. 1071-083A1 L-234  |
Levofloxacin-13C-d3 C17H17FN3O413CD3 M.W. 365.38 L-235  |
| Defluoro Levofloxacin CAS No. 117620-85-6 C18H21N3O4 M.W. 343.39 L-236  |
N,N’-Desethylene Levofloxacin C16H19N3O4 M.W. 317.35 L-237  |
| Levofloxacin Diamine C15H16FN3O4 M.W. 321.31 L-238  |
(R)-Levofloxacin C18H20FN3O4 M.W. 361.38 L-239  |
| Lomerizine diHCl C27H30F2N2O3.2 HCl M.W. 468.55 2 36.46 L-241  |
Lomerizine-d8 diHCl C27H22F2N2O3D8.2 HCl M.W. 476.60 2 36.46 L-242  |
| Lapatinib CAS No. 231277-92-2 C29H26ClFN4O4S M.W. 581.07 L-251  |
Lapatinib Impurity 9 CAS No. N/A C26H17ClFN3O3 M.W. 473.90 L-2510  |
| Lapatinib Impurity 10 CAS No. 1152131-73-1 C26H17ClFN3O4 M.W. 489.89 L-2511  |
Lapatinib 4-Fluoro Impurity CAS No. N/A C29H26ClFN4O4S M.W. 581.07 L-2512  |
| Lapatinib 2-Fluoro Impurity CAS No. N/A C29H26ClFN4O4S M.W. 581.07 L-2513  |
Lapatinib Hydroxylamine C29H26ClFN4O5S M.W. 597.07 L-2514  |
| Lapatinib-d5 C29H21ClFN4O4SD5 M.W. 586.10 L-252  |
Lapatinib-d4 Ditosylate CAS No. 388082-78-8 (non-labelled) C29H22ClFN4O4SD4 2C7H8O3S M.W. 585.09 2 172.20 L-253  |
| O-De(3-fluorobenzyl) Lapatinib Ditosylate Salt C22H21ClN4O4S . 2 C7H8O3S M.W. 472.95 2 172.20 L-254  |
Lapatinib Ditosylate CAS No. 388082-78-8 C29H26ClFN4O4S . 2 C7H8O3S . H2O M.W. 581.07 2 172.20 18.02 L-255  |
| Lapatinib Impurity 1 CAS No. 1268997-70-1 C22H21ClN4O4S M.W. 472.95 L-256  |
Lapatinib Impurity 2 CAS No. N/A C29H24ClFN4O4S M.W. 579.05 L-257  |
| Lapatinib Impurity 3 CAS No. N/A C26H20ClFN4O2 M.W. 474.93 L-258  |
Lapatinib Impurity 8 CAS No. N/A C26H19ClFN3O3 M.W. 475.91 L-259  |
| Lenalidomide CAS No. 191732-72-6 C13H13N3O3 M.W. 259.27 L-261  |
Lenalidomide-d5 CAS No. 191732-72-6 (non-d) C13H8N3O3D5 M.W. 264.35 L-262  |
| Lumiracoxib-acyl-β-D-glucuronide C21H21Cl2NO8 M.W. 486.31 L-271  |
Lumiracoxib CAS No. 220991-20-8 C15H13ClFNO2 M.W. 293.73 L-272  |
| Lacosamide CAS No. 175481-36-4 C13H18N2O3 M.W. 250.30 L-281  |
LAC2-IBCA C16H24N2O4 M.W. 308.38 L-2810  |
| LAC2 NMBA Impurity C14H20N2O3 M.W. 264.33 L-2811  |
(S)-Lacosamide C13H18N2O3 M.W. 250.30 L-2812  |
| (R)-O-Acetyl-Lacosamide CAS No. 1318777-54-6 C14H18N2O4 M.W. 278.31 L-2813  |
Lacosamide-d3 CAS No. 175481-36-4 (non-d) C13H15N2O3D3 M.W. 253.36 L-282  |
| Lacosamide-d3 C13H15N2O3D3 M.W. 253.32 L-283  |
N-Desacetyl Lacosamide HCl C11H16N2O2.HCl M.W. 208.26 36.46 L-284  |
| Lacosamide-d6 C13H12N2O3D6 M.W. 256.34 L-285  |
Benzylamine CAS No. 100-46-9 C7H9N M.W. 107.16 L-286  |
| Desmethyl Lacosamide CAS No. 175481-38-6 C12H16N2O3 M.W. 236.27 L-287  |
O-Acetyl Lacosamide CAS No. N/A C14H18N2O4 M.W. 278.31 L-288  |
| Desacetyl Desmethyl Lacosamide CAS No. N/A C10H14N2O2 M.W. 194.24 L-289  |
Lumenfantrine CAS No. 82186-77-4 C30H32Cl3NO M.W. 528.95 L-291  |
| Lumenfantrine-d9 CAS No. 82186-77-4 (non-d) C30H23Cl3NOD9 M.W. 538.01 L-292  |
Lumenfantrine glucuronide (mixture of diasteromers) C36H40Cl3NO7 M.W. 705.08 L-293  |
| N-Desbutyl Lumefantrine C26H24Cl3NO M.W. 472.85 L-294  |
Lumenfantrine Impurity A CAS No. NA C30H32Cl3NO M.W. 528.95 L-295  |
| Keto Impurity CAS No. NA C23H27Cl2NO2 M.W. 420.38 L-296  |
2-(2,7-Dichloro-9H-fluoren-4-yl)oxirane CAS No. N/A C15H10Cl2O M.W. 277.15 L-297  |
| 2-(Dibutylamino)-1-(2,7-dichloro-9H-fluoren-4-yl)ethanol CAS No. N/A C23H29Cl2NO M.W. 406.40 L-298  |
Lopinavir C37H48N4O5 M.W. 628.82 L-301  |
| Lopinavir-d8 C37H40N4O5D8 M.W. 636.87 L-302  |
Lopinavir Impurity S CAS No. N/A C47H58N4O7 M.W. 791.01 L-303  |
| Lopinavir Impurity T CAS No. N/A C57H66N4O7 M.W. 919.18 L-304  |
Lopinavir metabolite M1 CAS No. 192725-39-6 C37H46N4O6 M.W. 642.80 L-305  |
| Lopinavir metabolite M3-M4 CAS No. 357275-54-8 C37H48N4O6 M.W. 644.82 L-306  |
Lopinavir Impurity R C47H58N4O7 M.W. 791.01 L-307  |
| 4-Oxo Lopinavir C37H46N4O5 M.W. 626.80 L-308  |
12-Hydroxy Lauric Acid-d20 CAS No. 505-95-3 (non-d) C12H4O3D20 M.W. 236.44 L-311  |
| 12-Hydroxy Lauric Acid C12H24O3 M.W. 216.32 L-312  |
Latanoprost CAS No. 130209-82-4 C26H40O5 M.W. 432.61 L-321  |
| 15-Keto Latanoprost Acid C23H32O5 M.W. 388.51 L-3210  |
Latanoprost Impurity (Diphenylphosphine Isopropyl Ester) CAS No. N/A C20H25O3P M.W. 344.39 L-3211  |
| 9-Acetyl Latanoprost CAS No. N/A C28H42O6 M.W. 474.64 L-3212  |
Tafluprost CAS No. 209860-87-7 C25H34F2O5 M.W. 452.54 L-3213  |
| Tafluprost acid CAS No. 209860-88-8 C22H28F2O5 M.W. 410.46 L-3214  |
15(S)-Latanoprost CAS No. 145773-22-4 C26H40O5 M.W. 432.61 L-322  |
| 5-trans-Latanoprost C26H40O5 M.W. 432.60 L-3222  |
15-Keto Latanoprost C26H38O5 M.W. 430.59 L-323  |
| 5,6-trans-Latanoprost (50.0 mg in 5.0 ml methyl acetate) C26H40O5 M.W. 432.61 L-324  |
trans (15S)-Latanoprost CAS No. trans (15S)-Latanoprost C26H40O5 M.W. 432.61 L-325  |
| Latanoprost acid CAS No. 41639-83-2 C23H34O5 M.W. 390.52 L-326  |
15(R)-trans-Latanoprost (10.0 mg in 1.0 ml methyl acetate) C26H40O5 M.W. 432.61 L-328  |
| Latanoprost Epoxide (mixture of isomers) C26H40O6 M.W. 448.61 L-329  |
Lupeol C30H50O M.W. 426.73 L-331  |
| Levosulpiride CAS No. 23672-07-3 C15H23N3O4S M.W. 341.43 L-341  |
Levosulpiride-d3 C15H20D3N3O4S M.W. 344.44 L-342  |
| Lornoxicam CAS No. 70374-39-9 C13H10ClN3O4S2 M.W. 371.82 L-351  |
Lornoxicam Impurity 9 CAS No. 70374-36-6 C5H4ClNO4S2 M.W. 241.67 L-3510  |
| Lornoxicam Impurity 1 C12H8ClN3O6S3 M.W. 421.86 L-352  |
Lornoxicam Impurity 2 C12H10ClN3O5S3 M.W. 407.88 L-353  |
| Lornoxicam Impurity 3 CAS No. N/A C5H3ClO4S2 M.W. 226.66 L-354  |
Lornoxicam Impurity 4 CAS No. N/A C9H12ClNO6S2 M.W. 329.78 L-355  |
| Lornoxicam Impurity 5 CAS No. N/A C9H13ClN2O5S2 M.W. 328.80 L-356  |
Lornoxicam Impurity 6 C6H5ClO4S2 M.W. 240.69 L-357  |
| Lornoxicam Impurity 7 C7H6N2O3 M.W. 166.14 L-358  |
Lornoxicam Impurity 8 CAS No. 187746-94-7 C5H3ClO5S2 M.W. 242.66 L-359  |
| Luliconazole CAS No. 187164-19-8 Luliconazole M.W. 354.28 L-361  |
(R)-(Z)-Luliconazole Isomer C14H9Cl2N3S2 M.W. 354.28 L-362  |
| (S)-(E)-Luliconazole Isomer CAS No. 256424-63-2 C14H9Cl2N3S2 M.W. 354.28 L-363  |
Luliconazole Z-Isomer C14H9Cl2N3S2 M.W. 354.28 L-364  |
| Laropiprant CAS No. 571170-77-9 C21H19ClFNO4S M.W. 435.91 L-371  |
Laropiprant-d4 CAS No. 1132664-22-2 C21H15ClFNO4SD4 M.W. 439.96 L-372  |
| R-Laropiprant C21H19ClFNO4S M.W. 435.91 L-373  |
S-Laropiprant C21H19ClFNO4S M.W. 435.91 L-374  |
| Levomefolate-d4 C20H21N7O6D4 M.W. 463.49 L-381  |
Levomefolate C20H25N7O6 M.W. 459.47 L-382  |
| Levomefolate-d5 C20H20N7O6D5 M.W. 464.50 L-383  |
Levomefolate-13C-d3 C20H22N7O6D3 M.W. 463.47 L-384  |
| Calcium Levomefolate (L-5-Methyltetrahydrofolate Calcium Salt.5H2O) C20H23N7O6.Ca.5 H2O M.W. 457.45 40.08 5 18.02 L-385  |
Loteprednol CAS No. 129260-79-3 C21H27ClO5 M.W. 394.90 L-391  |
| Loteprednol Etabonate CAS No. 82034-46-6 C24H31ClO7 M.W. 466.96 L-392  |
Loteprednol Etabonate-d3 C24H28ClO7D3 M.W. 469.98 L-393  |
| Loteprednol Etabonate-d5 CAS No. 82034-46-6 (non-labelled) C24H26ClO7D5 M.W. 471.99 L-394  |
Leuprolide Acetate (Leuprorelin Acetate) CAS No. 74381-53-6 C59H84N16O12.C2H4O2 M.W. 1269.48 L-411  |
| Leuprolide-d5 C59H79N16O12D5 M.W. 1214.46 L-412  |
Levosimendan CAS No. 141505-33-1 C14H12N6O M.W. 280.29 L-421  |
| Levosimendan Impurity (2-[2-[4-(2-Azidotetrahydro-3-Methyl-5-oxo-2-Furanyl)phenyl]hydrazinylidene]propanedinitrile) CAS No. 252638-01-0 C14H11N7O2 M.W. 309.29 L-422 ![Levosimendan Impurity (2-[2-[4-(2-Azidotetrahydro-3-Methyl-5-oxo-2-Furanyl)phenyl]hydrazinylidene]propanedinitrile)](http://www.tlcpharmachem.com/product_images/L-422.jpg) |
Levosimendan Impurity 1 C22H23N7O2 M.W. 417.47 L-423  |
| Levosimendan Impurity 2 C16H17N5O3 M.W. 327.35 L-424  |
Levosimendan Impurity 3 C30H30N12O3 M.W. 606.65 L-425  |
| Linagliptin CAS No. 668270-12-0 C25H28N8O2 M.W. 472.55 L-441  |
Linagliptin-d3 CAS No. N/A C25H25N8O2D3 M.W. 475.57 L-442  |
| Linagliptin Diene Impurity CAS No. N/A C25H28N8O2 M.W. 472.55 L-443  |
Linagliptin Dimer Impurity CAS No. N/A C52H59N17O4 M.W. 986.16 L-444  |
| Linagliptin Dimer Impurity 2 C50H56N16O4 M.W. 945.11 L-445  |
Linagliptin Phthalimide Impurity C33H32N8O4 M.W. 604.67 L-446  |
| Linagliptin Dimer Impurity 3 C52H60N16O4 M.W. 973.16 L-447  |
Levomedetomidine HCl CAS No. 119717-21-4 C13H17N2Cl M.W. 236.75 L-451  |
| Levomedetomidine C13H16N2 M.W. 200.29 L-452  |
Levothyroxine-13C6 C15H11I4NO4 M.W. 782.81 L-4601  |
| Levothyroxine acyl glucuronide C21H19I4NO10 M.W. 953.00 L-4602  |
Levothyroxine phenolic glucuronide C21H19I4NO10 M.W. 953.00 L-4603  |
| Levothyroxine sulfate C15H11I4NO7S M.W. 856.94 L-4604  |
O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-hydroxy-l-tyrosine C15H11I4NO5 M.W. 792.88 L-4605  |
| 2-Hydroxy-2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid C14H8I4O5 M.W. 763.83 L-4606  |
N-Formyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine C16H11I4NO5 M.W. 804.89 L-4607  |
| 2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetamide C14H9I4NO3 M.W. 746.85 L-4608  |
N-Acetyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine C17H13I4NO5 M.W. 818.91 L-4609  |
| 2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid C14H8I4O4 M.W. 747.84 L-4610  |
4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzaldehyde C13H6I4O3 M.W. 717.81 L-4611  |
| 4-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzoic acid C13H6I4O4 M.W. 733.81 L-4612  |
O-(4-Hydroxy-3,5-Diiodophenyl)-3,5-Diiodo-beta-Hydroxy-L-Tyrosine CAS No. N/A C15H11I4NO5 M.W. 792,88 L-4613  |
| (S)-2-Amino-3-[4-[4-(4-Hydroxy-3,5-Diiodophenoxy)-3,5-Diiodophenoxy]- 3,5-Diiodophenyl]propanoic Acid CAS No. N/A C21H13I6NO5 M.W. 1120.77 L-4614 ![(S)-2-Amino-3-[4-[4-(4-Hydroxy-3,5-Diiodophenoxy)-3,5-Diiodophenoxy]- 3,5-Diiodophenyl]propanoic Acid](http://www.tlcpharmachem.com/product_images/L-4614.jpg) |
Levothyroxine N-Methylamine C16H14I4N2O3 M.W. 789.92 L-4615  |
| Levothyroxine N-methylamide C16H14I4N2O3 M.W. 789.92 L-4616  |
3,5-Diiodo-L-tyrosine C9H9I2NO3 M.W. 432.99 L-4617  |
| Levothyroxine Related Compound (2-Acetamido-3-(4-acetoxy-3,5-diiodophenyl)propanoic Acid) CAS No. 153324-21-1 C13H13I2NO5 M.W. 517.06 L-4618  |
Levothyroxine Related Compound (N-Acetyl-3,5-Diiodo-L-Tyrosine) CAS No. 1027-28-7 C11H11I2NO4 M.W. 475.02 L-4619  |
| N-acetyl 3,5-diiodo-L-tyrosine methyl ester C12H13I2NO4 M.W. 489.05 L-4620  |
Bis(p-anisyl)iodonium bromide C14H14IO2.Br M.W. 341.17 79.90 L-4621  |
| 2-Acetamido-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl) propanoic acid C18H17I2NO5 M.W. 581.15 L-4622  |
2-Amino-3(3-bromo-4-(4-hydroxyphenoxy)-5-iodophenyl)propanoic acid C15H13BrINO4 M.W. 478.08 L-4623  |
| 2-Amino-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl)propanoic acid C16H15I2NO4 M.W. 539.11 L-4624  |
Methyl 2-acetamido-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl) Propanoate C19H19I2NO5 M.W. 595.18 L-4625  |
| Lafutidine CAS No. 118288-08-7 C22H29N3O4S M.W. 431.56 L-471  |
Lafutidine Impurity A C6H5NO3 M.W. 139.11 L-472  |
| Lafutidine Impurity B C22H29N3O5S M.W. 447.56 L-473  |
Lafutidine Impurity C C15H23N3O M.W. 261.37 L-474  |
| Lafutidine Impurity D C22H31N3O5S M.W. 449.57 L-475  |
Lafutidine-d10 C22H19N3O4SD10 M.W. 441.62 L-476  |
| Lafutidine Dihydro Impurity CAS No. N/A C22H31N3O4S M.W. 433.57 L-477  |
Labetalol CAS No. 36894-69-6 C19H24N2O3 M.W. 328.41 L-481  |
| Labetalol Impurity A CAS No. N/A C19H23NO4 M.W. 329.40 L-482  |
Labetalol Impurity B CAS No. N/A C19H25NO4 M.W. 343.43 L-483  |
| Labetalol-d6 C19H18N2O3D6 M.W. 334.45 L-484  |
Labetalol-d5 HCl C19H19N2O3D5. HCl M.W. 333.44 36.46 L-485  |
| Lobucavir C11H15N5O3 M.W. 265.27 L-491  |
rac-Lipoic Acid-d5 C8H9O2S2D5 M.W. 211.36 L-852  |
| 1,2,3-Trithiane-4-Pentanoic Acid (Thioctic Acid Impurity A) CAS No. 1204245-29-3 C8H14O2S3 M.W. 238.39 L-853  |
Lipoic Acid Related Compound CAS No. 916746-61-7 C12H23NO4S2 M.W. 309.45 L-854  |
| Dihydrolipoic Acid CAS No. 462-20-4 C8H16O2S2 M.W. 208.34 L-855  |
Levocarnitine Impurity B C10H16O4 M.W. 200.24 L-861  |
| Levocarnitine Impurity C C7H17N2O2 . Cl M.W. 161.23 35.45 L-862  |
Levocarnitine Impurity D C7H15N2O M.W. 143.21 L-863  |
| Lipstatin CAS No. 96829-59-3 C29H49NO5 M.W. 491.72 L-871  |
Lipstatin-d3 C29H46NO5D3 M.W. 494.74 L-872  |
| Linoleoyl Carnitine CAS No. 36816-10-1 C25H49NO4 M.W. 427.67 L-881  |
Loxoprofen CAS No. 68767-14-6 C15H18O3 M.W. 246.31 L-891  |
| Loxoprofen Ring-opening Impurity CAS No. 1091621-61-2 C15H18O5 M.W. 278.31 L-892  |
Loxoprofen related compound 1 C25H36O3 M.W. 384.56 L-893  |
| Loxoprofen related compound 2 C15H18O4 M.W. 262.31 L-894  |
Levamisole Phosphate CAS No. 32093-35-9 C11H12N2S. H3O4P M.W. 204.30 98.00 L-901  |
| Linolenic Acid CAS No. 463-40-1 C18H30O2 M.W. 278.44 L-911  |
Lycoramine CAS No. 21133-52-8 C17H23NO3 M.W. 289.38 L-921  |
联系方式
公司:深圳远扬生物技术有限公司
状态:离线 发送信件
姓名:何德华(先生)
电话:0755-89554301
手机:15012456311
传真:0755-89554301
地区:广东-深圳市
地址:深圳市龙岗区龙平东路郭尾新村11号604室
QQ:781007885
商铺:http://m.ceoie.com/781007885/
状态:离线 发送信件
姓名:何德华(先生)
电话:0755-89554301
手机:15012456311
传真:0755-89554301
地区:广东-深圳市
地址:深圳市龙岗区龙平东路郭尾新村11号604室
QQ:781007885
商铺:http://m.ceoie.com/781007885/
去深圳远扬生物技术有限公司怎么走？上图中的红点是深圳远扬生物技术有限公司在深圳市的具体位置标注，操作左上角地图工具可以放大缩小哦。
相关信息
[化学试剂] 推荐供应
最新发布信息
点击分享到微信、朋友圈、QQ...